184 related articles for article (PubMed ID: 34746127)
1. Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma.
Kang W; Hu J; Zhao Q; Song F
Front Cell Dev Biol; 2021; 9():731380. PubMed ID: 34746127
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma.
Hu J; Song F; Kang W; Xia F; Song Z; Wang Y; Li J; Zhao Q
Front Pharmacol; 2023; 14():1162563. PubMed ID: 37521469
[TBL] [Abstract][Full Text] [Related]
3. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
Front Oncol; 2022; 12():857994. PubMed ID: 35619896
[TBL] [Abstract][Full Text] [Related]
4. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
7. Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature.
Bao X; Shi R; Zhang K; Xin S; Li X; Zhao Y; Wang Y
Front Oncol; 2019; 9():903. PubMed ID: 31620363
[No Abstract] [Full Text] [Related]
8. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
Zheng D; Zhang Y; Xia Y; Cheng F
Front Oncol; 2022; 12():840410. PubMed ID: 35371994
[TBL] [Abstract][Full Text] [Related]
9. A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma.
Song J; Zhao Q; Xu Y; Zhu L
Int Immunopharmacol; 2020 Nov; 88():106994. PubMed ID: 33182060
[TBL] [Abstract][Full Text] [Related]
10. Construction of a Prognostic Nomogram Based on Autophagy-Related Genes for Children With Neuroblastoma.
Ye G; Wang Y
Evol Bioinform Online; 2022; 18():11769343221120960. PubMed ID: 36046056
[TBL] [Abstract][Full Text] [Related]
11. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
12. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
13. A risk signature of three autophagy-related genes for predicting lower grade glioma survival is associated with tumor immune microenvironment.
Lin JZ; Lin N
Genomics; 2021 Jan; 113(1 Pt 2):767-777. PubMed ID: 33069830
[TBL] [Abstract][Full Text] [Related]
14. A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response.
Yang J; Han L; Sha Y; Jin Y; Li Z; Gong B; Li J; Liu Y; Wang Y; Zhao Q
Front Immunol; 2022; 13():1061814. PubMed ID: 36605200
[TBL] [Abstract][Full Text] [Related]
15. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.
Zeng L; Xu H; Li SH; Xu SY; Chen K; Qin LJ; Miao L; Wang F; Deng L; Wang FH; Li L; Fu S; Liu N; Wang R; Li YQ; Wang HY
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37130627
[TBL] [Abstract][Full Text] [Related]
16. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
Li J; Li X; Zhang C; Zhang C; Wang H
Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
Yu Y; Zeng Y; Xia X; Zhou JG; Cao F
Cancer Control; 2021; 28():10732748211033751. PubMed ID: 34569303
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Model for Colon Cancer Patients Based on Eight Signature Autophagy Genes.
Xu J; Dai S; Yuan Y; Xiao Q; Ding K
Front Cell Dev Biol; 2020; 8():602174. PubMed ID: 33324651
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.
Xia Y; Li X; Tian X; Zhao Q
Front Mol Biosci; 2021; 8():769661. PubMed ID: 34950701
[No Abstract] [Full Text] [Related]
20. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]